GGrantIndex
Sort

64,565 grants matching drug discovery

Joint genomic and statistical analyses of schizophrenia and bipolar to decipher genetic susceptibility

$748,802
Roel A Ophoff · University Of California Los Angeles · R01 · FY2022 · MH

Evolution and inhibition of carbapenemase in beta-lactam resistance

$748,760
Yu Chen · University Of South Florida · R01 · FY2024 · AI

SBIR Phase II: High Speed Chemical Analysis of Combinatorial Libraries

$748,739
Jack Syage · Syagen Technology Inc · · FY2000 · TIP

Digital representation of chemical mixtures to aid drug discovery and formulation

$748,733
Barry A Bunin · Collaborative Drug Discovery, Inc. · R44 · FY2020 · TR

Emory-GSK-NIMH Collaborative Mood Disorders Initiative

$748,728
Emory University · U19 · FY2003 · MH

Novel antifungal agents against coccidioidomycosis

$748,714
Maciej Walczak · University Of Colorado · R01 · FY2025 · AI

Inhibiting poxvirus phosphatases: therapy and biodefense

$748,686
Medical College Of Wisconsin · U01 · FY2003 · AI

The CellRaft AIR System: Workflow Automation for Stem Cell Isolation and Recovery

$748,655
Nancy L Allbritton · Cell Microsystems, Inc. · R42 · FY2016 · GM

Discovery of allosteric activators of phospholipase C-gamma2 to treat Alzheimer's disease

$748,573
Qisheng Zhang · Univ Of North Carolina Chapel Hill · R56 · FY2024 · AG

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

$748,425
Andrew G Myers · Harvard University · R01 · FY2017 · CA

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

$748,425
Andrew G Myers · Harvard University · R01 · FY2020 · CA

Northeast Node of the National Drug Abuse Clinical Trials Network

$748,377
Lisa A Marsch · Dartmouth College · UG1 · FY2018 · DA

Northeast Node of the National Drug Abuse Clinical Trials Network

$748,377
Lisa A Marsch · Dartmouth College · UG1 · FY2019 · DA

Northeast Node of the National Drug Abuse Clinical Trials Network

$748,377
Lisa A Marsch · Dartmouth College · UG1 · FY2016 · DA

Northeast Node of the National Drug Abuse Clinical Trials Network

$748,377
Lisa A Marsch · Dartmouth College · UG1 · FY2017 · DA

VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS

$748,362
Satya Prakash Saxena · Calibrant Biosystems, Inc. · R42 · FY2008 · CA

Genetic Variation in Opioid Induced Respiratory Depression in Mice

$748,295
Jason A Bubier · Jackson Laboratory · R01 · FY2020 · DA

NIDA Epidemiology Training Program

$748,284
C Debra Furr-Holden · Johns Hopkins University · T32 · FY2014 · DA

A Scalable Platform to Discover Antimicrobials of Ribosomal Origin

$748,142
Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2021 · AI

Defining an Obesity QTL on Chromosome 3q

$748,126
Loyola University Chicago · R01 · FY2004 · HL

Clinical and Translational Science Award

$748,112
Robert Stanley Sherwin · Yale University · UL1 · FY2009 · RR

Physiological and therapeutic effects of ANGPTL3 variants in mice and humans

$748,107
Marina Cuchel · University Of Pennsylvania · R01 · FY2022 · HL

Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease

$748,092
Mark W Albers · Massachusetts General Hospital · R01 · FY2021 · AG

UT Southwestern NCI National Clinical Trials Network Lead Academic Site

$747,907
David Eric Gerber · Ut Southwestern Medical Center · UG1 · FY2024 · CA

BIODIVERSITY UTILIZATION IN MADAGASCAR AND SURINAME

$747,882
Virginia Polytechnic Inst And St Univ · U01 · FY2000 · TW